Market Commentary     24-May-24
Mid-Session
Benchmarks trade falt; oil & gas shares rally for 9th day in row
The key equity indices traded near the flat line in early afternoon trade. The Nifty traded below the 23,000 level after hitting the day's high of 23,004.05 in morning trade. Oil & gas shares extended gains for the nine consecutive trading sessions.

At 12:27 IST, the barometer index, the S&P BSE Sensex, was down 10.3 points or 0.02% to 75,407.76. The Nifty 50 index shed 3.40 points or 0.01% to 22,964.25.

The broader market outperformed the headline indices. The S&P BSE Mid-Cap index added 0.52% and the S&P BSE Small-Cap index rose 0.39%.

The market breadth was positive. On the BSE, 1,857 shares rose and 1,836 shares fell. A total of 139 shares were unchanged.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rose 0.99% to 21.59. The Nifty 30 May 2024 futures were trading at 23,001.05, at a premium of 36.8 points as compared with the spot at 22,964.25.

The Nifty option chain for the 30 May 2024 expiry showed maximum Call OI of 101.3 lakh contracts at the 24,000 strike price. Maximum Put OI of 73 lakh contracts were seen at 23,000 strike price.

Buzzing Index:

The Nifty Oil & Gas index rose 0.71% to 12,015.25. The index advanced 6.67% in the nine consecutive trading sessions.

Adani Total Gas (up 3.91%), GAIL (India) (up 2.29%), Aegis Logistics (up 2.21%), Hindustan Petroleum Corporation (HPCL) (up 1.78%), Bharat Petroleum Corporation (BPCL) (up 1.48%), Indian Oil Corporation (up 1.13%), Indraprastha Gas (up 0.98%), Mahanagar Gas (up 0.49%), Gujarat Gas (up 0.46%) and Castrol India (up 0.34%) edged higher.

On the other hand, Petronet LNG (down 0.6%), Reliance Industries (down 0.36%) and Gujarat State Petronet (down 0.15%) slipped.

Stocks in Spotlight :

Bikaji Foods International jumped 4.74% after the company reported a consolidated net profit of Rs 116.24 crore in Q4 FY24, steeply higher than Rs 38.10 crore posted in Q4 FY23. Revenue from operations grew by 12.81% year on year to Rs 520.83 crore during the quarter.

Biocon gained 2.31% after the company announced the signing of an exclusive licensing and supply agreement with South Korea-based Handok for the commercialization of its vertically integrated & complex drug product Synthetic Liraglutide.

Previous News
  Biocon to conduct board meeting
 ( Corporate News - 18-Jul-24   10:37 )
  Biocon Ltd eases for fifth straight session
 ( Hot Pursuit - 12-Jul-24   13:36 )
  Bikaji Foods International to table results
 ( Corporate News - 26-Jun-24   17:37 )
  Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
 ( Hot Pursuit - 24-Jun-24   09:34 )
  Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
 ( Corporate News - 24-Jun-24   09:01 )
  Biocon’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 15-Jun-24   16:32 )
  Biocon appoints Interim CFO
 ( Corporate News - 11-Jun-24   17:16 )
  Biocon Ltd soars 2.25%, up for fifth straight session
 ( Hot Pursuit - 11-Jun-24   13:00 )
  Biocon Ltd spurts 1.22%, gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Biocon gets US FDA nod for fungal infection drug
 ( Hot Pursuit - 04-Jun-24   11:18 )
  J Kumar Infraprojects Ltd leads gainers in 'A' group
 ( Hot Pursuit - 31-May-24   12:00 )
Other Stories
  Market at day’s low, auto shares under pressure
  19-Jul-24   14:43
  Indices trade near day’s low; European mkt decline
  19-Jul-24   13:35
  Nifty slides below 24,650; realty shares under pressure
  19-Jul-24   12:33
  Sensex slides 337 pts; oil & gas shares decline
  19-Jul-24   11:35
  Broader market underperforms; metal shares slide
  19-Jul-24   10:36
  Barometers drift lower; Nifty below 24,800; breadth negative
  19-Jul-24   09:42
  Market at day's high; financial services in demand
  18-Jul-24   14:41
  Sensex breaches 81k; Nifty tops 24,700; European mkt opens higher
  18-Jul-24   13:32
  Indices trade flat; IT shares advance
  18-Jul-24   12:33
  Broader market underperforms; media shares slide
  18-Jul-24   11:36
Back Top